Atezolizumab plus taxane chemotherapy for the treatment of non-BRAF, non-RAS mutated anaplastic thyroid carcinoma: Final analysis.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sarah Hamidi, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan M. Fellman, Michelle D. Williams, Mark E. Zafereo, Rui Jennifer Wang, Charles Lu, Matthew S. Ning, Brian McKinley, Scott Eric Woodman, Dzifa Yawa Duose, Gary Brandon Gunn, Naifa Lamki Busaidy, Maria E. Cabanillas
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399486009